ARS Pharmaceuticals, Inc. — 8-K Filings
60 8-K filings on record
This page lists all 8-K filings submitted to the SEC by ARS Pharmaceuticals, Inc. (SPRY), sorted by most recent first. Each row links to the full filing on EdgarLookup. ARS Pharmaceuticals, Inc. has filed 60 8-K documents with the SEC since 2016. To view all SEC filings by ARS Pharmaceuticals, Inc., see the full filings list.
All
10-K
10-Q
10-Q/A
144
144/A
3
3/A
4
4/A
424B4
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DEFM14A
DRS
EFFECT
PREM14A
PRER14A
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0001193125-21-326031 | Nov 10, 2021 | — |
| 8-K | 8-K | 0001193125-21-274662 | Sep 16, 2021 | — |
| 8-K | 8-K | 0001193125-21-270925 | Sep 13, 2021 | — |
| 8-K | 8-K | 0001193125-21-244702 | Aug 12, 2021 | — |
| 8-K | 8-K | 0001193125-21-207593 | Jul 2, 2021 | Jul 1, 2021 |
| 8-K | 8-K | 0001193125-21-186730 | Jun 9, 2021 | Jun 4, 2021 |
| 8-K | 8-K | 0001193125-21-160511 | May 13, 2021 | — |
| 8-K | 8-K | 0001193125-21-098282 | Mar 29, 2021 | — |
| 8-K | 8-K | 0001193125-21-081351 | Mar 15, 2021 | Mar 12, 2021 |
| 8-K | 8-K | 0001193125-20-312895 | Dec 8, 2020 | — |